Work

Brentuximab Vedotin Plus Bendamustine: A Highly Active Salvage Treatment Regimen for Patients with Relapsed or Refractory Hodgkin Lymphoma

Year: 2015

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v126.23.3982.3982

Authors: Ann S. LaCasce, Gregory Bociek, Ahmed Sawas, Paolo F. Caimi, Edward Agura, Jeffrey Matous, Stephen Ansell, Howland Crosswell, Miguel Islas-Ohlmayer, Caroline Behler, Eric Cheung, Andres Forero-Torres, Julie Vose, Owen A. O'Connor, Neil Josephson, Ranjana Advani

Institutions: Dana-Farber Cancer Institute, University of Nebraska Medical Center, Columbia University Irving Medical Center, University Hospitals Cleveland Medical Center, Colorado Blood Cancer Institute, Mayo Clinic, Mercy Health, Jewish Hospital, Oncology Institute of Hope and Innovation, University of Alabama at Birmingham, Seagen (United States), Stanford Medicine, Stanford University

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2336054546

FWCI: 10.78

Cites:

Cited by: 62

Related to: 10